Syneos Health Inc (NASDAQ/NGS (GLOBAL SELECT MARKET):SYNH)

Expected performance: Start your 30-days free trial
About the company

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

CEO

Alistair Macdonald

Exchange

NASDAQ/NGS (GLOBAL SELECT MARKET)

Website

www.syneoshealth.com

$4B

Total Revenue

24K

Employees

$9B

Market Capitalization

47.70

Price/Earning ratio

Stock price

Gross Margin (%)

Total gross margin

$1044M

Operating Margin (%)

Total operating margin

$361M

Net Margin (%)

Total net margin

$198M

Dividend Yield (%)

Dividend per share

$0

90-days Stock Price Forecast (%)

PREDICT MONTHLY

$29.9 / Month

  • 4000+ Daily forecasts
  • Company fundamentals
  • Follow list
  • Industry leaderboard
  • Portfolio optimization
  • Billed monthly
  • Cancel anytime

OPTIMIZE YEARLY

$479.9 / Year

  • 4000+ Daily forecasts
  • Company fundamentals
  • Follow list
  • Industry leaderboard
  • Portfolio optimization
  • Billed yearly
  • Cancel anytime

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (%)
Charles River Laboratories International Inc. CRL 20752.92 3041.00 9.36 55.14 12.33
Exact Sciences Corp. EXAS 16823.04 1546.00 5.07 -22.10 -48.20
PRA Health Sciences Inc PRAH 10738.65 3333.00 6.88 50.52 6.40
Syneos Health Inc SYNH 9415.35 4461.00 2.85 47.70 4.44
Medpace Holdings Inc MEDP 6685.72 955.00 7.43 41.69 16.67
Twist Bioscience Corp TWST 5537.25 113.00 9.80 -47.69 -109.15
Exelixis Inc EXEL 5375.15 1031.00 2.76 84.25 6.28
Recursion Pharmaceuticals Inc RXRX 4734.60 6.00 -21.99 -47.42 None
Vir Biotechnology Inc VIR 4420.60 73.00 7.12 -11.43 -537.46
Allakos Inc ALLK 4057.56 None 6.92 -22.29 None
Cerevel Therapeutics Holdings Inc CERE 3129.28 None 10.27 -20.88 None
Sana Biotechnology Inc SANA 2915.91 None 3.47 -6.73 None
Lyell Immunopharma Inc LYEL 2900.00 9.00 -10.51 -12.72 None
Allogene Therapeutics Inc ALLO 2765.70 38.00 2.90 -11.99 -596.57
Alx Oncology Holdings Inc ALXO 2342.40 1.00 5.63 -40.95 -401.23
Sorrento Therapeutics Inc SRNE 2126.39 47.00 10.53 -8.83 -496.04
Instil Bio Inc TIL 1941.45 0.00 2.91 -34.20 None
Organogenesis Holdings Inc ORGO 1825.46 379.00 12.47 39.33 11.66
Rubius Therapeutics Inc RUBY 1740.69 None 6.38 -10.80 None
Cortexyme Inc CRTX 1638.79 None 10.68 -20.18 None
Constellation Pharmaceuticals Inc CNST 1563.54 None 4.32 -11.18 None
Replimune Group Inc REPL 1505.58 None 3.07 -18.70 None
Pandion Therapeutics Inc PAND 1501.25 1069.00 1.83 -13.34 -10.55
Castle Biosciences Inc CSTL 1466.85 68.00 4.18 -94.39 -22.24
National Research Corp NRC 1372.28 135.00 18.33 39.10 25.71
Y-Mabs Therapeutics Inc YMAB 1357.10 26.00 5.72 -21.22 -228.62
Century Therapeutics Inc IPSC 1224.30 None -17.46 -19.43 None
AlloVir Inc ALVR 1186.68 0.00 3.62 -13.11 -718.59
Verve Therapeutics Inc VERV 1069.74 None -35.80 -20.93 None
Cullinan Oncology Inc CGEM 1008.92 19.00 2.14 -21.23 -247.56
Scholar Rock Holding Corp SRRK 1000.00 15.00 4.47 -10.45 -643.75
Precigen Inc PGEN 960.75 98.00 6.46 -7.22 -134.74
Design Therapeutics Inc DSGN 851.40 0.00 2.11 -64.50 -245.44
Prometheus Biosciences Inc RXDX 817.83 2.00 2.72 -21.40 None
RAPT Therapeutics Inc RAPT 766.75 5.00 9.83 -13.39 7.14
Ideaya Biosciences Inc IDYA 686.00 27.00 4.02 -22.48 -117.50
Sutro Biopharma Inc STRO 647.14 50.00 2.56 -21.02 -85.39
Finch Therapeutics Group Inc FNCH 618.99 9.00 2.61 -13.72 -479.12
Day One Biopharmaceuticals Inc DAWN 616.72 None -21.37 -26.95 None
Crinetics Pharmaceuticals Inc CRNX 593.34 0.00 4.52 -7.49 -447.78
Talaris Therapeutics Inc TALS 566.21 None -12.33 -20.92 None
MeiraGTx Holdings plc MGTX 559.60 16.00 2.80 -8.48 -413.39
Precision Biosciences Inc DTIL 522.58 34.00 9.67 -5.19 -299.85
Clene Inc CLNN 516.00 0.00 -14.58 -9.35 None
Vor Biopharma Inc VOR 463.24 None 1.74 -8.29 None
Werewolf Therapeutics Inc HOWL 452.92 None -3.12 -4.03 None
Luna Innovations Inc LUNA 406.89 92.00 5.05 94.85 4.45
Evelo Biosciences Inc EVLO 405.24 None 5.58 -4.17 None
Applied Therapeutics Inc APLT 395.83 14.00 3.32 -3.67 -19.41
Alzamend Neuro Inc ALZN 393.83 None -221.25 -88.50 None
Mirum Pharmaceuticals Inc MIRM 390.15 None 3.28 -2.94 None
Vera Therapeutics Inc VERA 360.00 None -4.10 -6.62 None
Oyster Point Pharma Inc OYST 356.25 None 2.17 -4.95 None
Biomea Fusion Inc BMEA 356.13 None 1319.00 -32.97 None
Black Diamond Therapeutics Inc BDTX 344.16 None 1.23 -4.02 None
Magenta Therapeutics Inc MGTA 327.52 None 3.22 -4.56 None
Cue Biopharma Inc CUE 312.60 4.00 4.69 -6.99 -986.92
Impel NeuroPharma Inc. IMPL 267.14 None -2.17 -5.79 None
Surface Oncology Inc SURF 246.41 89.00 1.64 13.07 23.77
Sensei Biotherapeutics Inc SNSE 244.59 None 1.41 -10.38 None
AquaBounty Technologies Inc AQB 227.70 0.00 1.52 -12.37 None
Hookipa Pharma Inc HOOK 216.44 21.00 1.64 -4.32 -237.83
Kezar Life Sciences Inc KZR 214.28 None 1.67 -5.41 None
Gemini Therapeutics Inc GMTX 211.37 1088.00 0.23 1.74 11.24
INmune Bio Inc INMB 197.86 0.00 3.80 -13.35 None
Reneo Pharmaceuticals Inc RPHM 196.56 None -4.07 -8.90 None
Janux Therapeutics Inc JANX 194.58 0.00 -81.08 -28.70 None
Nextcure Inc NXTC 194.04 22.00 0.69 -3.04 -163.57
Unity Biotechnology Inc UBX 192.92 1.00 2.49 -2.36 None
Pieris Pharmaceuticals Inc PIRS 191.40 32.00 5.27 -5.12 -119.28
Cabaletta Bio Inc CABA 171.58 None 1.80 -4.91 None
BioVie Inc BIVI 141.40 None 27.73 -1.67 None
Axcella Health Inc AXLA 119.00 None 2.09 -2.22 None
Exicure Inc XCUR 117.45 8.00 2.37 -3.14 -454.43
Orgenesis Inc ORGS 112.70 15.00 2.20 -1.24 -455.65
Gain Therapeutics Inc GANX 96.00 0.00 2.14 -17.39 None
Cyclerion Therapeutics Inc CYCN 93.12 1.00 2.43 -1.31 None
Rezolute Inc RZLT 77.95 None 3.19 -4.37 None
Scopus Biopharma Inc SCPS 74.40 None 18.60 -5.34 None
CohBar Inc CWBR 59.36 None 4.31 -3.73 None
Monopar Therapeutics Inc MNPR 58.41 None 2.65 -8.30 None
Cytocom Inc CBLI 55.90 0.00 7.29 -23.89 -912.16
Eloxx Pharmaceuticals Inc ELOX 52.80 0.00 44.00 -1.81 -14.14
Vaccinex Inc VCNX 51.45 1.00 81.67 -1.81 -48.71
AgeX Therapeutics Inc AGE 51.30 2.00 -8.44 -5.00 -532.21
Cyclo Therapeutics Inc CYTH 49.80 1.00 3.69 -1.98 -989.80
Aridis Pharmaceuticals Inc ARDS 44.91 1.00 -6.57 -2.01 -851.00
NanoViricides Inc NNVC 40.20 None 1.45 -7.05 None
Synaptogenix Inc SNPX 30.40 None 2.98 -1.69 None
Xenetic Biosciences Inc XBIO 28.49 1.00 3.26 -2.45 -47.40
Kiromic BioPharma Inc KRBP 22.47 None 5.84 -1.09 None
Tenax Therapeutics Inc TENX 15.57 0.00 14.42 -0.67 -840.64
Geovax Labs Inc GOVX 13.11 1.00 1.34 39.73 -322.24
Neurotrope Inc NTRP 4.70 29.00 0.08 0.76 23.48

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Is Syneos Health, Inc.'s (NASDAQ:SYNH) Recent Stock Performance Influenced By Its Financials In Any Way?

10d ago, source: Yahoo Finance

Syneos Health's (NASDAQ:SYNH) stock is up by 3.9% over the past month. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually ...

Could The Syneos Health, Inc. (NASDAQ:SYNH) Ownership Structure Tell Us Something Useful?

10d ago, source: Nasdaq

Every investor in Syneos Health, Inc. (NASDAQ:SYNH) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see insiders ...

Syneos Health appoints Michael Brooks as Chief Development Officer

8d ago, source: pharmaphorum.com

Syneos Health has appointed Michael Brooks as its new chief development officer. In this newly created role, Brooks will lead ...

Syneos Health Inc Class A 8IN

6d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

People spotlight — July 2021

3d ago, source: pharmaceuticalcommerce

The latest people news happenings over the past month ...

The Worldwide Clinical Trial Industry is Expected to Reach a Value of $57+ Billion by 2026 - ResearchAndMarkets.com

9d ago, source: Yahoo Finance

The global clinical trials market will reach the value of US$ 57.46 Billion by 2026. Companies Covered: ICON Plc Wuxi AppTec SGS SA Syneos Health PRA Health Sciences Inc The clinical trial is a human ...

Is Syneos Health, Inc.'s (NASDAQ:SYNH) Recent Stock Performance Influenced By Its Financials In Any Way?

10d ago, source: Yahoo Finance

Syneos Health's (NASDAQ:SYNH) stock is up by 3.9% over the past month. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually ...

Your Portfolio

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.